Who owns INHIBIKASE THERAPEUTICS INC?
- Ticker: IKT
- CUSIP Number: 45719w205
Tip: Access positions for across all investors
Analyze quarterly positions in Inhibikase Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Inhibikase Therapeutics stock
Who bought or sold INHIBIKASE THERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Sands Capital Ventures | 13M | $22M | 0% | Mar 2026 |
|
| Soleus Capital Management | 11M | $18M | 0% | Mar 2026 |
|
| Fairmount Funds Management | 8.6M | $15M | 0% | Mar 2026 |
|
| Trails Edge Capital Partners | 8.1M | $14M | 100% | Mar 2026 |
|
| ADAR1 Capital Management | 6.6M | $11M | -18% | Mar 2026 |
|
| BlackRock | 6.3M | $11M | 91% | Mar 2026 |
|
| Blackstone Group | 5.9M | $10M | 0% | Mar 2026 |
|
| Siren | 5.9M | $9.8M | 0% | Mar 2026 |
|
| Commodore Capital | 5.4M | $9.1M | 0% | Mar 2026 |
|
| Vanguard Capital Management | 4.5M | $7.5M | 100% | Mar 2026 |
|
| Saturn V Capital Management | 3.9M | $6.5M | 0% | Mar 2026 |
|
| Kalehua Capital Management | 3.8M | $6.4M | 100% | Mar 2026 |
|
| Squadron Capital Management | 3.5M | $5.9M | 100% | Mar 2026 |
|
| Millennium Management | 2.9M | $4.9M | 1624% | Mar 2026 |
|
| Nantahala Capital Management | 2.7M | $4.5M | -31% | Mar 2026 |
|
| Perceptive Advisors | 2.3M | $3.9M | -57% | Mar 2026 |
|
| Geode Capital Management | 2.2M | $3.6M | 92% | Mar 2026 |
|
| State Street Corporation | 1.7M | $2.8M | 204% | Mar 2026 |
|
| SummitTX Capital | 1.5M | $2.6M | 100% | Mar 2026 |
|
| Integral Health Asset Management | 1.4M | $2.3M | -23% | Mar 2026 |
|
| Ally Bridge Group | 1.3M | $2.2M | 100% | Mar 2026 |
|
| Citadel Advisors | 1.1M | $1.9M | -11% | Mar 2026 |
|
| Stonepine Capital Management | 957k | $1.6M | -59% | Mar 2026 |
|
| Two Sigma Investments | 848k | $1.4M | 100% | Mar 2026 |
|
| Northern Trust | 719k | $1.2M | 123% | Mar 2026 |
|
| Vanguard Portfolio Management | 618k | $1.0M | 100% | Mar 2026 |
|
| Vanguard Fiduciary Trust | 567k | $953k | 100% | Mar 2026 |
|
| Nuveen | 472k | $794k | 501% | Mar 2026 |
|
| Seven Fleet Capital Management | 326k | $547k | -39% | Mar 2026 |
|
| Bank of America Corporation | 323k | $542k | 100% | Mar 2026 |
|
| Charles Schwab Investment Management | 235k | $396k | 55% | Mar 2026 |
|
| UBS Group | 228k | $383k | 141% | Mar 2026 |
|
| Rangeley Capital | 220k | $370k | 100% | Mar 2026 |
|
| Bank of New York Mellon | 213k | $358k | 55% | Mar 2026 |
|
| AQR Capital Management | 172k | $289k | 100% | Mar 2026 |
|
| Morgan Stanley | 164k | $276k | 106% | Mar 2026 |
|
| William Blair $ Company | 158k | $265k | 3% | Mar 2026 |
|
| Goldman Sachs Group | 150k | $252k | 76% | Mar 2026 |
|
| Algert Coldiron Investors | 134k | $225k | 100% | Mar 2026 |
|
| Deutsche Bank Aktiengesellschaft | 122k | $206k | 123% | Mar 2026 |
|
| FMR | 72k | $121k | 25% | Mar 2026 |
|
| MetLife Investment Advisors | 63k | $106k | 100% | Mar 2026 |
|
| Rhumbline Advisers | 59k | $99k | 24% | Mar 2026 |
|
| Mirae Asset Global Etfs Holdings | 50k | $85k | 74% | Mar 2026 |
|
| Sei Investments | 48k | $81k | 100% | Mar 2026 |
|
| New York State Common Retirement Fund | 48k | $81k | 0% | Mar 2026 |
|
| Wells Fargo & Company | 41k | $68k | -40% | Mar 2026 |
|
| Point72 Asset Management | 40k | $68k | 100% | Mar 2026 |
|
| XTX Topco | 39k | $65k | 92% | Mar 2026 |
|
| Vanguard Global Advisers | 37k | $61k | 100% | Mar 2026 |
|
| Quadrature Capital | 36k | $61k | 100% | Mar 2026 |
|
| Susquehanna International | 35k | $59k | 63% | Mar 2026 |
|
| Invesco | 34k | $58k | 6% | Mar 2026 |
|
| Jones Financial Companies, L.L | 32k | $54k | 100% | Mar 2026 |
|
| Squarepoint Ops | 31k | $52k | 100% | Mar 2026 |
|
| Manufacturers Life Insurance Company | 29k | $48k | 100% | Mar 2026 |
|
| Caxton | 29k | $48k | 0% | Mar 2026 |
|
| Intech Investment Management | 27k | $45k | 0% | Mar 2026 |
|
| Fifth Lane Capital | 25k | $42k | 100% | Mar 2026 |
|
| Virtu Financial | 25k | $41k | 8% | Mar 2026 |
|
| Ccg Wealth Management | 24k | $41k | 100% | Mar 2026 |
|
| Bnp Paribas Arbitrage, Snc | 23k | $38k | 76% | Mar 2026 |
|
| Barclays | 21k | $36k | -77% | Mar 2026 |
|
| Balyasny Asset Management | 18k | $30k | 100% | Mar 2026 |
|
| Police & Firemen's Retirement System of New Jersey | 18k | $30k | 0% | Mar 2026 |
|
| Tower Research Capital | 17k | $29k | 167% | Mar 2026 |
|
| Ing Investment Management | 17k | $28k | 29% | Mar 2026 |
|
| Renaissance Technologies | 17k | $28k | 100% | Mar 2026 |
|
| CWM | 16k | $28k | 22392% | Mar 2026 |
|
| Transcend Wealth Collective | 16k | $27k | 100% | Mar 2026 |
|
| Ieq Capital | 16k | $27k | 100% | Mar 2026 |
|
| ProShare Advisors | 16k | $26k | 41% | Mar 2026 |
|
| SG Americas Securities | 16k | $26k | 100% | Mar 2026 |
|
| Prudential Financial | 15k | $26k | 100% | Mar 2026 |
|
| Abel Hall | 15k | $25k | 100% | Mar 2026 |
|
| Buckingham Strategic Partners | 12k | $20k | 11% | Mar 2026 |
|
| Victory Capital Management | 11k | $18k | -7% | Mar 2026 |
|
| U.S. Capital Wealth Advisors | 10k | $17k | 100% | Mar 2026 |
|
| Legal & General Group | 9.4k | $16k | 71% | Mar 2026 |
|
| Russell Investments | 6.5k | $11k | -40% | Mar 2026 |
|
| Summit Investment Advisors | 6.2k | $10k | 0% | Mar 2026 |
|
| California State Teachers Retirement System | 5.9k | $9.9k | 58% | Mar 2026 |
|
| Pinnacle Wealth Planning Services | 5.4k | $9.1k | 0% | Mar 2026 |
|
| Citigroup | 5.0k | $8.4k | 100% | Mar 2026 |
|
| Advisor Group Holdings | 4.0k | $6.7k | 100% | Mar 2026 |
|
| Sterling Capital Management | 3.3k | $5.5k | 2% | Mar 2026 |
|
| Essential Partners | 2.6k | $4.4k | 100% | Mar 2026 |
|
| Royal Bank of Canada | 1.6k | $3.0k | 100% | Mar 2026 |
|
| True Wealth Design | 499.00 | $1.0k | 1060% | Jun 2026 |
|
| Hanson McClain Advisors | 383.00 | $644.014500 | 38200% | Mar 2026 |
|
| Farther Finance Advisors | 370.00 | $749.990000 | 436% | Jun 2026 |
|
| Caitong International Asset Management | 261.00 | $438.010200 | 100% | Mar 2026 |
|
| EverSource Wealth Advisors | 213.00 | $319.500000 | 5225% | Mar 2026 |
|
| MAI Wealth Advisors | 91.00 | $152.998300 | 100% | Mar 2026 |
|
| Pnc Financial Services | 81.00 | $135.999000 | -20% | Mar 2026 |
|
| SRS Capital Advisors | 49.00 | $82.001500 | 100% | Mar 2026 |
|
| Rothschild Investment | 28.00 | $47.000800 | 100% | Mar 2026 |
|
| Sunbelt Securities | 28.00 | $47.000800 | 100% | Mar 2026 |
|
| SJS Investment Consulting | 9.00 | $16.000200 | 100% | Mar 2026 |
|
| IFP Advisors | 3.00 | $5.000100 | 100% | Mar 2026 |
|
Who sold out of Inhibikase Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Ameriprise Financial | Dec 2025 | 1.4M | $2.8M |
| Exome Asset Management | Dec 2025 | 600k | $1.2M |
| Jane Street | Dec 2025 | 116k | $238k |
| Persistent Asset Partners | Dec 2025 | 93k | $192k |
| Scientech Research | Dec 2025 | 16k | $33k |
| Sanctuary Advisors | Dec 2025 | 13k | $26k |
| Hrt Financial | Dec 2025 | 11k | $21k |
| Amalgamated Bank | Dec 2025 | 1.9k | $4.0k |
| GAMMA Investing | Mar 2026 | 411.00 | $689.986800 |